Carfilzomib Supplier-Buyer Network — Trade Flow Analysis

Name: Carfilzomib Supplier-Buyer Trade Network Dataset — 65+ Indian Exporters, 12+ Importers, 47+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Carfilzomib supplier network, Carfilzomib buyers, pharmaceutical export India, Carfilzomib trade data

TransData Nexus

Carfilzomib

India Pharmaceutical Trade Intelligence

$1.2M65 Suppliers47 CountriesHS 30049049

ExportsIndia → RUSSIA60.7%India → CHILE7.4%

ImportsIRELAND → India$9.4M CANADA → India$518.8K

#1 Supplier: MSN LABORATORIES

Who Supplies Carfilzomib? Top Manufacturers & Buyers 2026 — MSN LABORATORIES PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1MSN LABORATORIES PRIVATE LIMITED

MSN LABORATORIES PRIVATE LIMITED is the first-largest Carfilzomib exporter from India, with a market share of 60.7% and a total export value of $737.1K across 19 shipments. Their average shipment value of $38.8K is above the market average of $6.0K, suggesting premium or bulk contract pricing.

MSN LABORATORIES PRIVATE LIMITED serves 1 named buyer in our database. OOO"JODAS EXPOIM" is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• OOO"JODAS EXPOIM" — $737.1K across 19 shipments (100.0% of this supplier's total exports)

Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $38.8K is 549% above the market average of $6.0K, consistent with large-order contracts or value-added formulations.

2SARTAJ PHARMA PRIVATE LIMITED

SARTAJ PHARMA PRIVATE LIMITED is the second-largest Carfilzomib exporter from India, with a market share of 7.5% and a total export value of $90.8K across 7 shipments. Their average shipment value of $13.0K is above the market average of $6.0K, suggesting premium or bulk contract pricing.

SARTAJ PHARMA PRIVATE LIMITED serves 5 named buyers in our database. MSN LABS CHILE SPARU is the dominant customer, accounting for 98.8% of this supplier's tracked business. Top customers include:

• MSN LABS CHILE SPARU — $89.7K across 7 shipments (98.8% of this supplier's total exports)

• MSN LABS BRASIL LTDA — $484 across 0 shipments (0.5% of this supplier's total exports)

• SAFE LAB LOGISTICS S — $253 across 0 shipments (0.3% of this supplier's total exports)

• SANDOZ DO BRASIL IND — $240 across 0 shipments (0.3% of this supplier's total exports)

• SANDOZ DO BRASIL IND — $158 across 0 shipments (0.2% of this supplier's total exports)

Key Insight: SARTAJ PHARMA PRIVATE LIMITED's per-shipment value of $13.0K is 117% above the market average of $6.0K, consistent with large-order contracts or value-added formulations.

3NATCO PHARMA LIMITED

NATCO PHARMA LIMITED is the third-largest Carfilzomib exporter from India, with a market share of 4.4% and a total export value of $53.3K across 7 shipments. Their average shipment value of $7.6K is above the market average of $6.0K, suggesting premium or bulk contract pricing.

NATCO PHARMA LIMITED serves 1 named buyer in our database. ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA — $53.3K across 7 shipments (100.0% of this supplier's total exports)

Key Insight: NATCO PHARMA LIMITED's per-shipment value of $7.6K is 27% above the market average of $6.0K, consistent with large-order contracts or value-added formulations.

43S CORPORATION

3S CORPORATION is the fourth-largest Carfilzomib exporter from India, with a market share of 2.7% and a total export value of $32.9K across 8 shipments. Their average shipment value of $4.1K is below the market average of $6.0K, reflecting a high-volume, competitive pricing strategy.

3S CORPORATION serves 3 named buyers in our database. RAFTAR MARIME FZE is the dominant customer, accounting for 58.3% of this supplier's tracked business. Top customers include:

• RAFTAR MARIME FZE — $19.2K across 5 shipments (58.3% of this supplier's total exports)

• SARTAJ ENTERPRIESES — $11.7K across 3 shipments (35.6% of this supplier's total exports)

• TO THE ORDER OF THE — $2.0K across 0 shipments (6.1% of this supplier's total exports)

Key Insight: 3S CORPORATION operates with high shipment frequency (8 shipments) at a per-shipment value of $4.1K, indicating a broad distribution network with many smaller, regular orders.

5MBA PHARMACEUTICALS PRIVATE LIMITED

MBA PHARMACEUTICALS PRIVATE LIMITED is the fifth-largest Carfilzomib exporter from India, with a market share of 2.1% and a total export value of $25.7K across 13 shipments. Their average shipment value of $2.0K is below the market average of $6.0K, reflecting a high-volume, competitive pricing strategy.

MBA PHARMACEUTICALS PRIVATE LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• FOR THE ORDER OF — $12.8K across 6 shipments (49.8% of this supplier's total exports)

• FOR THE ORDER OF — $5.4K across 3 shipments (21.0% of this supplier's total exports)

• M S FOR THE ORDER OF — $5.1K across 3 shipments (19.9% of this supplier's total exports)

• FOR THE ORDER OF — $2.4K across 1 shipments (9.3% of this supplier's total exports)

Key Insight: MBA PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (13 shipments) at a per-shipment value of $2.0K, indicating a broad distribution network with many smaller, regular orders.

6RGSK CANADA HEALTHCARE INC.

RGSK CANADA HEALTHCARE INC. is the fifth-largest Carfilzomib exporter from India, with a market share of 2.1% and a total export value of $25.0K across 7 shipments. Their average shipment value of $3.6K is below the market average of $6.0K, reflecting a high-volume, competitive pricing strategy.

RGSK CANADA HEALTHCARE INC. serves 3 named buyers in our database. EVEREST BANK LTD is the dominant customer, accounting for 77.7% of this supplier's tracked business. Top customers include:

• EVEREST BANK LTD — $19.5K across 5 shipments (77.7% of this supplier's total exports)

• EVEREST BANK LIMITED — $3.5K across 1 shipments (13.9% of this supplier's total exports)

• D K M PHARMACEUTICAL — $2.1K across 1 shipments (8.3% of this supplier's total exports)

Key Insight: RGSK CANADA HEALTHCARE INC. operates with high shipment frequency (7 shipments) at a per-shipment value of $3.6K, indicating a broad distribution network with many smaller, regular orders.

1Russia

Russia ranks as the first-largest destination for Carfilzomib imports from India, with a total trade value of $737.1K across 0 shipments — representing a 60.7% share of all Carfilzomib exports. The average shipment value of $737.1K is above the global average of $6.0K, indicating high-value procurement contracts or branded formulations.

Key Insight: Russia's per-shipment average of $737.1K (12231% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Carfilzomib imports from India.

Primary Market

Secondary Market

2Chile

Chile ranks as the second-largest destination for Carfilzomib imports from India, with a total trade value of $89.7K across 0 shipments — representing a 7.4% share of all Carfilzomib exports. The average shipment value of $89.7K is above the global average of $6.0K, indicating high-value procurement contracts or branded formulations.

Key Insight: Chile's per-shipment average of $89.7K (1400% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Chile is a key market for Carfilzomib imports from India.

Primary Market

Secondary Market

3Ecuador

Ecuador ranks as the third-largest destination for Carfilzomib imports from India, with a total trade value of $53.3K across 2 shipments — representing a 4.4% share of all Carfilzomib exports. The average shipment value of $26.6K is above the global average of $6.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Carfilzomib importers in Ecuador: ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA is the largest buyer, accounting for 100.0% ($53.3K) of this market's total imports.

• ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA — $53.3K (100.0% of Ecuador's total)

Key Insight: Ecuador's per-shipment average of $26.6K (346% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ecuador is a key market for Carfilzomib imports from India.

Primary Market

Secondary Market

4United Arab Emirates

United Arab Emirates ranks as the fourth-largest destination for Carfilzomib imports from India, with a total trade value of $48.9K across 4 shipments — representing a 4.0% share of all Carfilzomib exports. The average shipment value of $12.2K is above the global average of $6.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Carfilzomib importers in United Arab Emirates: RAFTAR MARIME FZE is the largest buyer, accounting for 39.2% ($19.2K) of this market's total imports.

• RAFTAR MARIME FZE — $19.2K (39.2% of United Arab Emirates's total)

Key Insight: United Arab Emirates's per-shipment average of $12.2K (104% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Arab Emirates is a key market for Carfilzomib imports from India.

Primary Market

Secondary Market

5Armenia

Armenia ranks as the fifth-largest destination for Carfilzomib imports from India, with a total trade value of $43.1K across 8 shipments — representing a 3.5% share of all Carfilzomib exports. The average shipment value of $5.4K is below the global average of $6.0K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Carfilzomib importers in Armenia: VLADIMIR GASPARYAN is the largest buyer, accounting for 53.8% ($23.2K) of this market's total imports.

• VLADIMIR GASPARYAN — $23.2K (53.8% of Armenia's total)

• VLADIMIR GASPARYAN APP — $11.6K (27.0% of Armenia's total)

Key Insight: Armenia receives frequent, smaller shipments of Carfilzomib — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Armenia is a key market for Carfilzomib imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Carfilzomib.
2.Flow Mapping: 65 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 203 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 47 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

203 Verified Shipments

65 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Carfilzomib

Carfilzomib

Who Supplies Carfilzomib? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Carfilzomib? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Carfilzomib Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MSN LABORATORIES PRIVATE LIMITED

2SARTAJ PHARMA PRIVATE LIMITED

3NATCO PHARMA LIMITED

43S CORPORATION

5MBA PHARMACEUTICALS PRIVATE LIMITED

6RGSK CANADA HEALTHCARE INC.

From Indian Factories to Global Pharmacies — How Carfilzomib Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Carfilzomib Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Russia

2Chile

3Ecuador

4United Arab Emirates

5Armenia

People Also Ask — Carfilzomib Supplier & Trade Network

Carfilzomib Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology